The automation of single-use processes for commercial biologics manufacturing

Single-use technology has been widely adopted by the biopharmaceutical industry for pre-clinical and clinical manufacturing. There is increasing interest in applying this technology for the commercial production of biological drugs. This raises a number of questions the industry must address as it considers its facilities of the future. These include, what do biomanufacturers require their single-use automation be capable of when used for commercial production? How do these needs differ from what is currently available for non-commercial manufacturing and how can we close the gap?

To discuss these challenges, industry needs and potential solutions, we invite you an exclusive dining event sponsored by the Sartorius Integrated Solutions team. Held at a 5-star or equivalent restaurant, you will have the opportunity to network with executives and senior managers from within the biopharmaceutical industry.

Prior to dinner, you will be able to hear our guest presenter, an expert on single-use automation, give their perspective on how the landscape could and should evolve. Furthermore, you will hear from our Sartorius Integrated Solutions experts who will contribute their experience.

Following dinner, our invited expert will moderate a discussion allowing you to voice your opinions and articulate your view of industry requirements. We are sure there will be a lively and enjoyable discussion.

About Sartorius Integrated Solutions:
Sartorius Integrated Solutions designs and implements rapid and cost-effective biomanufacturing processes – enabling your project to move seamlessly from process development to clinical through to commercial manufacturing. We are capable of providing fully single-use, hybrid or traditional stainless steel systems that fulfil your unique manufacturing needs.